IRIS
MESSINA, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.764
AS - Asia 1.677
NA - Nord America 1.465
SA - Sud America 379
AF - Africa 30
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.321
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.392
RU - Federazione Russa 1.113
SG - Singapore 589
CN - Cina 549
BR - Brasile 309
IT - Italia 229
HK - Hong Kong 191
VN - Vietnam 159
SE - Svezia 138
FR - Francia 68
BD - Bangladesh 61
DE - Germania 57
GB - Regno Unito 36
CA - Canada 33
AR - Argentina 31
MX - Messico 30
IN - India 25
FI - Finlandia 21
IE - Irlanda 18
PL - Polonia 18
ES - Italia 15
EC - Ecuador 12
ID - Indonesia 12
TR - Turchia 12
JP - Giappone 10
NL - Olanda 10
CO - Colombia 9
ZA - Sudafrica 9
AT - Austria 8
IQ - Iraq 8
JO - Giordania 8
UA - Ucraina 8
LT - Lituania 7
CL - Cile 6
MY - Malesia 6
SA - Arabia Saudita 6
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
DK - Danimarca 4
PK - Pakistan 4
UZ - Uzbekistan 4
CH - Svizzera 3
KE - Kenya 3
KR - Corea 3
KZ - Kazakistan 3
MA - Marocco 3
NO - Norvegia 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
VE - Venezuela 3
ZW - Zimbabwe 3
BE - Belgio 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JM - Giamaica 2
KW - Kuwait 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
MK - Macedonia 1
MW - Malawi 1
SY - Repubblica araba siriana 1
Totale 5.321
Salva come PNG Salva come JPEG
Città #
Dallas 396
Singapore 301
Moscow 212
Ashburn 190
Hong Kong 187
San Jose 128
Shanghai 93
Hefei 72
New York 67
Ho Chi Minh City 57
Milan 57
Lauterbourg 56
Beijing 47
São Paulo 41
Los Angeles 40
Lawrence 38
Princeton 38
Rome 29
Munich 25
Council Bluffs 24
Santa Clara 24
Hanoi 23
Boardman 21
Orem 21
Dublin 18
Denver 17
Warsaw 17
Montreal 15
Guangzhou 13
Chennai 12
Nuremberg 12
Stockholm 11
Turin 11
Atlanta 10
Biên Hòa 10
Curitiba 10
Houston 10
Seattle 10
Helsinki 9
Manchester 9
Mexico City 9
Phoenix 9
Tokyo 9
Amman 8
Buffalo 8
Chicago 8
Florence 8
Poplar 8
Tianjin 8
Ankara 7
Haiphong 7
Turku 7
Brasília 6
Brooklyn 6
Da Nang 6
Genoa 6
Hải Dương 6
Johannesburg 6
Naples 6
Perugia 6
Querétaro 6
Washington 6
Belo Horizonte 5
Bergamo 5
Betim 5
Bogotá 5
Hangzhou 5
Lappeenranta 5
London 5
Porto Alegre 5
Quito 5
Recife 5
Rho 5
Ribeirão das Neves 5
Rio de Janeiro 5
Shenzhen 5
Amsterdam 4
Baghdad 4
Boston 4
Charlotte 4
Cincinnati 4
Falkenstein 4
Marostica 4
Olímpia 4
Padua 4
Passo Fundo 4
Pisa 4
San Francisco 4
St Louis 4
St Petersburg 4
Tashkent 4
The Dalles 4
Vienna 4
Bologna 3
Buenos Aires 3
Calgary 3
Camarillo 3
Cesano Boscone 3
Coimbatore 3
Copenhagen 3
Totale 2.696
Salva come PNG Salva come JPEG
Nome #
A novel scoring approach to identify responders to erenumab in clinical practice 181
Resting State Functional Connectivity Changes of the Pons in Migraine Patients: A Cross-Sectional and Longitudinal Study 171
Alterations of brain structural MRI are associated with outcome of surgical treatment in trigeminal neuralgia 165
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 145
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 118
Imaging the brain and vascular reactions to headache treatments: a systematic review 117
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients 115
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 114
Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study 110
Imaging of Migraine and Vestibular Migraine 106
Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study 102
Brain connectivity abnormalities extend beyond the sensorimotor network in peripheral neuropathy 98
Tension-type headache 95
Extent and characteristics of carotid plaques and brain parenchymal loss in asymptomatic patients with no indication for revascularization 92
An update on migraine: current understanding and future directions 92
Biomarkers of Migraine and Cluster Headache: Differences and Similarities 90
Clinical correlates of hypothalamic functional changes in migraine patients 90
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 88
Myocardial infarction in a patient with migraine and triptan overuse treated with anti-CGRP receptor monoclonal antibody: a case report 87
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study 86
CGRP – a target for acute therapy in migraine: Clinical data 85
Stress in paediatric migraine: a trigger factor? 84
Candesartan in migraine prevention: results from a retrospective real-world study 83
Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study 82
Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability 82
Tracking the evolution of non-headache symptoms through the migraine attack 81
Functional MRI in migraine 79
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study 78
Cortical abnormalities in patients with migraine: a surface-based analysis. 75
DIFFERENCES IN BRAIN STRUCTURE AND FUNCTION IN PRIMARY HEADACHE DISORDERS: A MULTIMODAL MRI STUDY 73
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 72
Erenumab effect on brain network function in episodic migraine patients: a randomized, placebo-controlled, clinical trial 71
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 70
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study 69
Dysregulation of multisensory processing stands out from an early stage of migraine: a study in pediatric patients 69
Brain structural and functional abnormalities in Fahr's disease: a report of two cases 68
Neural correlates of visuospatial processing in migraine: does the pain network help? 67
A review of recent literature on functional MRI and personal experience in two cases of definite vestibular migraine 66
Insights into migraine attacks from neuroimaging 63
An Altered Hypothalamic-Pontine Functional Interplay Could Affect Migraine Disease Progression Over the Years 63
A novel scoring approach to identify responders to erenumab in clinical practice 63
Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis. 62
Relation between characteristics of carotid atherosclerotic plaques and brain white matter hyperintensities in asymptomatic patients 59
What imaging has revealed about migraine and chronic migraine 58
Regional cervical cord atrophy and disability in multiple sclerosis: a voxel-based analysis. 56
The Chronic Migraine Brain: What Have We Learned From Neuroimaging? 56
Editorial: Functional and Structural Brain Alterations in Headache: A Trait or a State? 56
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE) 54
Unveiling Functional and Structural Brain MRI Alterations in Opioid Use Disorder 54
Pathophysiological Bases of Comorbidity in Migraine 54
Structural brain abnormalities in patients with vestibular migraine 53
Author response: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study 53
Refractory chronic migraine: is drug withdrawal necessary before starting a therapy with onabotulinum toxin type A? 51
Recent advances in headache neuroimaging 51
What We Gain From Machine Learning Studies in Headache Patients 50
Distributed abnormalities of brain white matter architecture in patients with dominant optic atrophy and OPA1 mutations 49
Gray matter volume modifications in migraine: A cross-sectional and longitudinal study 49
White matter microstructure abnormalities in pediatric migraine patients 46
Editorial: Still Searching for the Origin of Migraine: From Comorbidities to Chronicization 44
Multiple sclerosis imaging: recent advances. 43
Imaging the migrainous brain: the present and the future 43
Resting-state fMRI functional connectivity: a new perspective to evaluate pain modulation in migraine? 42
Estimating brain lesion volume change in multiple sclerosis by subtraction of magnetic resonance images 39
Structural brain MRI abnormalities in pediatric patients with migraine 39
fMRI of the sensorimotor system 39
Imaging of migraine and vestibular migraine 39
fMRI of pain 38
Biomarkers of treatment response 37
Exploring the role of the pons and hypothalamus in migraine disease progression 37
Resting State Functional Connectivity Changes of the Hypothalamus in Migraine Patients: A Cross-Sectional and Longitudinal Study 35
Neural Correlates of Visuospatial Processing in Migraine Patients: Does the Pain Network Interfere? 34
Resting State Functional Connectivity Changes of the Hypothalamus in Migraine Patients: A Cross-Sectional and Longitudinal Study 33
MRI studies can predict progression of disease years before it occurs 32
Neural correlates of visuospatial processing in migraine patients: does the pain network interfere? 32
Neural correlates of visuospatial processing in migraine patients: does the pain network interfere? 29
RESTING STATE FUNCTIONAL CONNECTIVITY CHANGES OF THE HYPOTHALAMUS IN MIGRAINE PATIENTS: A CROSS-SECTIONAL AND LONGITUDINAL STUDY 27
Migraine treatments: what have we learned from neuroimaging? 24
Super- and absolute responders to anti-cgrp monoclonal antibodies in migraine: A one-year multicenter, prospective, observational study 22
Insights into Migraine Treatments. Towards Personalized Medicine 20
Unveiling Resting-State Functional Connectivity Patterns in Patients With Migraine: A REFORM Study 9
Interventions for Migraine and Sleep: A Systematic Review Exploring Their Bidirectional Association 8
Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis 7
Combining treatments for migraine prophylaxis: the state-of-the-art 3
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society 3
Health equity, care access and quality in headache – part 2 3
Exploring the role of the pons and hypothalamus in migraine progression 2
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials 2
Exploring the role of the pons and hypothalamus in migraine progression 2
Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members’ vision – part 1 2
Totale 5.485
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.783
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202234 0 1 1 11 0 4 5 2 1 1 6 2
2022/2023255 88 50 26 1 7 29 15 18 7 1 7 6
2023/2024258 6 11 31 22 41 36 8 32 7 9 16 39
2024/2025925 95 23 28 23 44 85 77 91 141 154 71 93
2025/20263.978 258 312 419 511 270 147 283 274 1.035 186 166 117
Totale 5.485